Pathogenic Spectrum and Drug Resistance Analysis of Infectious Pneumonia of Patients in the First
People's Hospital of Dali City from 2016 to 2017
Yang Min1, Ding Yibo2, Li Liuqin1, Wang Peng2*
(1. Department of Respiration, The First People's Hospital of Dali City, Dali, Yunnan 671000, China; 2. Yunnan Provincial Key
Laboratory for Zoonosis Disease Control and Prevention, Yunnan Institute for Endemic Diseases Control and Prevention,
Dali, Yunnan 671000, China)
YANG Min, DING Yi-Bo, LI Liu-Qin, WANG Feng. Pathogenic Spectrum and Drug Resistance Analysis of Infectious Pneumonia of Patients in the First
People's Hospital of Dali City from 2016 to 2017[J]. , 2019, 4(8): 76-81.
〔1〕NDIP R N,NTIEGE E A,NDIP L M,et al. Antimicrobial
resistance of bacterial agents of the upper respiratory tract
of school children in Buea,Cameroon〔J〕. J Health Popul
Nutr,2008,26(4):397-404.
〔2〕MURRAY C J L,LOPEZ A D. Mortality by cause for eight
regions of the world:Global Burden of Disease Study〔J〕.
Lancet,1997,349(9061):1269-1276.
〔3〕中华人民共和国卫生部医政司. 全国临床检验操作规
程〔M〕. 3版. 南京:东南大学出版社,2006.
〔4〕陈鸿羽,李媛媛,邓春. 2010至2014年我院新生儿肺炎
主要病原菌分布及耐药性变迁〔J〕. 重庆医科大学学报,
2017,42(1):42-49.
〔5〕刘雪茹,熊小丽,陈鹏. 下呼吸道感染患儿的病原菌分布
及耐药性分析〔J〕. 中华医院感染学杂志,2017,27(4):
911-914.
〔6〕王武华. 下呼吸道感染患者痰培养病原菌分布及耐药性
检测〔J〕. 山东医药,2016,56(42):90-92.
〔7〕史金英,张丽娟,张惠芬,等. 呼吸重症监护病房下呼吸
道真菌感染病原谱及临床分析〔J〕. 河北医药,2009,31
(4):427-428.
〔8〕杨畅,胡东辉,冯燕. 下呼吸道感染患者病原菌分布及耐药
情况分析〔J〕. 现代预防医学,2014,41(20):3818-3820.
〔9〕曹新民,李祯. 呼吸道感染中病原谱及抗生素的耐药情
况分析〔J〕. 现代预防医学,2014,41(16):3049-3051.
〔10〕王云娟,宋贵波,苏艳丹,等. 2013—2015年云南省三级
医院尿培养病原菌分布及耐药性分析〔J〕. 中国抗生素
杂志,2017,42(7):548-560.
〔11〕赵卫东,严萍,忽胜和,等. 云南大理医院ICU产ESBLs
细菌基因型及耐药性分析〔J〕. 中国病原生物学杂志,
2012,7(8):618-620.
〔12〕LAUTENBACH E,PATEL J B,BILKER W B,et al. Ex?
tended-spectrum beta-lactamase-producing Escherichia
coli and Klebsiella pneumoniae:risk factors for infection
and impact of resistance on outcomes〔J〕. Clin Infect Dis,
2001,32(8):1162-1171.
〔13〕张蕾,许晶,史伟,等. 西安地区呼吸道疾病病毒病原谱
分析〔J〕. 现代预防医学,2015,42(6):1099-1103.